Shares of Cepheid rose 7.5 percent for the five-day trading period ended Tuesday. The trading week was cut short a few hours on Tuesday in advance of the Independence Day holiday in the US.

 

Cepheid and Becton Dickinson were mentioned in an article in Friday’s edition of The Wall Street Journal focused on new testing methods for antibiotic resistance in hospitals. The firms make the only Food and Drug Administration-cleared molecular-based tests for methicillin-resistant Streptococcus aureus.